Drug recall

Blood and Blood Products for Reprocessing

FDA recall event 77863 · Class II · Carter BloodCare

Key facts

Event ID 77863
Recall numbers B-0783-2017, B-0784-2017
Recalling firm Carter BloodCare
Product type Biologics
Products Blood and Blood Products for Reprocessing, Red Blood Cells, Leukocytes Reduced
Classification Class II
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall Blood products, for which the donor's screening record was incomplete, were distributed.
Initiation date Jul 25, 2017
Report date Aug 16, 2017
Termination date Aug 10, 2017
City Bedford
State TX
Country United States
FEI number 3002603147

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls